sibutramine has been researched along with reboxetine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkenfeld, AL; Diedrich, A; Jordan, J; Luft, FC; Mayer, AF; Schroeder, C; Tank, J | 1 |
| Babbs, AJ; Chatfield, RE; Krülle, TM; McCormack, JG; Provost, D; Thomas, GH; Widdowson, PS | 1 |
| Cárdenas, M; Gómez-Flores, JR; González-Hermosillo, JA; Márquez, MF; Ruíz-Siller, TJ | 1 |
1 review(s) available for sibutramine and reboxetine
| Article | Year |
|---|---|
[Role of the sympathetic nervous system in vasovagal syncope and rationale for beta-blockers and norepinephrine transporter inhibitors].
Topics: Adrenergic beta-Antagonists; Baroreflex; Cyclobutanes; Heart Rate; Humans; Molecular Biology; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Reboxetine; Sympathetic Nervous System; Syncope, Vasovagal | 2016 |
1 trial(s) available for sibutramine and reboxetine
| Article | Year |
|---|---|
Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.
Topics: Blood Pressure; Cross-Over Studies; Cyclobutanes; Double-Blind Method; Head-Down Tilt; Heart Rate; Humans; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Posture; Reboxetine; Syncope | 2006 |
1 other study(ies) available for sibutramine and reboxetine
| Article | Year |
|---|---|
5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Appetite Depressants; Blood Pressure; Cyclobutanes; Dose-Response Relationship, Drug; Eating; Fluoxetine; Heart Rate; Male; Models, Animal; Morpholines; Norepinephrine; Pyrimidines; Rats; Rats, Sprague-Dawley; Reboxetine; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Triazines | 2009 |